Antenatal Dexamethasone for Late Preterm Deliveries
Status:
Not yet recruiting
Trial end date:
2024-03-30
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to compare dexamethasone in late preterm deliveries. The
main questions it aims to answer are: Does antenatal dexamethasone reduce the need for
respiratory support in late preterm infants? Does antenatal dexamethasone reduce neonatal
morbidities and mortality? Does antenatal dexamethasone reduce admission to Neonatal
Intensive Care Unit and length of hospital stay? Participants will be allocated into 2
groups: intervention with dexamethasone IM and placebo. Investigators will compare these two
groups to see if antenatal dexamethasone reduces the need for respiratory support in late
preterm infants, neonatal morbidities and mortality, admission to NICU and length of hospital
stay.